Neil F. McFarlane - 06 Apr 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role: Director
Signature: /s/ Colleen Tupper as Attorney-in-Fact for Neil F. McFarlane
Issuer symbol: COLL
Transactions as of: 06 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 08 Apr 2022, 17:12:30 UTC
Previous filing: 24 Nov 2021
Next filing: 23 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COLL	Common Stock	Award	$0	+17,845		$0.000000	17,845	06 Apr 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 6, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Content

Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 6, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.